You are here: Home » Companies » News
Business Standard

Next-gen to take up key roles

Lupin promotes Vinita Gupta as CEO, Nilesh Gupta as MD

BS Reporter  |  Mumbai 

Lupin, India’s third-largest pharmaceuticals company by market capitalisation, is seeing a change at the helm. Today, the company’s board of directors appointed Vinita Gupta, daughter of Chairman D B Gupta, as chief executive officer, while her brother, Nilesh Gupta was appointed managing director.

Nilesh Gupta succeeds Kamal K Sharma, who has been promoted to the post of vice-chairman. The appointment is effective from 1st September, 2013

As chief executive of Lupin Pharmaceuticals, the company’s US subsidiary, Vinita Gupta, 45, played a key role in increasing Lupin’s revenue from the US market. Under her leadership, the company became the fifth-largest generic company in the US, with a revenue of $700 million. Vinita has a graduate degree in pharmacy from the University of Mumbai and a master’s degree in business administration from the J L Kellogg Graduate School of Management.

Currently, Nilesh Gupta is group president and executive director in the Lupin board. He is a chemical engineer from the University Department of Chemical Technology, Mumbai, and a graduate with honours from the Wharton School, University of Pennsylvania. He is responsible for all research and development activities — drug discovery, process research, formulation research and intellectual property management.

Last year, Samina Vaziralli, daughter of Cipla’s joint managing director M K Hamied, was inducted into the Cipla management.

Dear Reader,

Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.
We, however, have a request.

As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.

Support quality journalism and subscribe to Business Standard.

Digital Editor

First Published: Thu, May 09 2013. 00:35 IST